CAS: 92623-85-3; Milnacipran Hydrochloride

该化合物是一种有机环丙烷衍生物,配有盒式氨基甲基功能组和一个氨基甲基替代体.它的立体化学学,由(1R,2S)-替代品组合定义,可能会影响其在对应选择性应用中的结合性或反应性. 极地(碳甲胺,氨基甲基)和非极地(苯基,二乙基)组的存在表明在制药合成或不对称催化中具有潜在效用. 环丙烷环具有结构僵硬性,可以增强目标互动的稳定性或选择性. 这一组合的模块结构允许进一步功能化,使它成为医药化学或材料科学研究的多功能建筑块.

结构式图片

合成工艺路线路线简述

  • 105310-75-6 = 92623-85-3
    反应条件:1.1 Reagents: Hydrazine Solvents: Ethanol
    标题:1-Aryl-2-(Aminomethyl)Cyclopropanecarboxylic Acid Derivatives. A New Series Of Potential Antidepressants
    作者:Bonnaud,Bernard; Cousse,Henri; Mouzin,Gilbert; Briley,Mike; Stenger,Antoine; Et Al
    参考文献:Journal Of Medicinal Chemistry 日期:1987 卷标:30(2) 页码:318-25]

    = 92623-85-3
    反应条件:1.1 Reagents: Triphenylphosphine Solvents: Toluene; 30 Min,Rt; 1 H,Rt
    标题:An Improved Process For The Preparation Of 1-Aryl-2-Aminomethylcyclopropanecarboxamide Derivatives,Their Isomers And Salts
    参考文献:India]

    = 92623-85-3 [标题:Reaction Conditions
    标题:In Vivo And In Vitro Olefin Cyclopropanation Catalyzed By Engineered And Chimeric Heme Enzymes
    参考文献:World Intellectual Property Organization]

    = 92623-85-3 [标题:Reaction Conditions
    标题:Process For The Preparation Of Milnacipran Hydrochloride
    参考文献:India]

    = 92623-85-3 [标题:Reaction Conditions
    标题:Process For Preparing Optically Pure Milnacipran And Its Pharmaceutically Acceptable Salts Via Salt Resolution
    参考文献:India]

    101152-94-7 = 92623-85-3
    反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Dichloromethane,Water; Ph 10.5,Rt
    标题:Process For Preparing Optically Pure Milnacipran And Its Pharmaceutically Acceptable Salts Via Salt Resolution
    参考文献:World Intellectual Property Organization]

    = 92623-85-3
    反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Dichloromethane; 30 Min,Rt
    标题:Modular Synthesis Of Cyclopropane-Fused N-Heterocycles Enabled By Underexplored Diazo Reagents
    作者:Richter,Matthieu J. R.; Zecri,Frederic J.; Briner,Karin; Schreiber,Stuart L.
    参考文献:Angewandte Chemie 日期:2022 卷标:61(38)]

    = 92623-85-3
    反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Water
    标题:Milnacipran As A Challenging Example Of Aminomethyl Substrate For Lipase-Catalyzed Kinetic Resolution
    作者:Sanfilippo,Claudia; Nicolosi,Giovanni; Patti,Angela
    参考文献:Journal Of Molecular Catalysis B: Enzymatic 日期:2014 卷标:104 页码:82-86]

    101152-94-7 = 92623-85-3
    反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Dichloromethane,Water
    标题:A Process For The Preparation Of Levomilnacipran
    参考文献:Italy]

    105310-75-6 = 92623-85-3
    反应条件:1.1 Reagents: Methylamine; 2 H,Rt
    标题:An Improved Process For The Preparation Of Milnacipran And Salts Thereof
    参考文献:India]

    105310-75-6 = 92623-85-3
    反应条件:1.1 Reagents: Methylamine Solvents: Toluene,Water; 24 H,20 - 30 °C
    标题:Improved Process For The Preparation Of (Z)-2-Aminomethyl-1-Phenyl-N,N-Diethylcyclopropanecarboxamide
    参考文献:India]

    105310-75-6 = 92623-85-3
    反应条件:1.1 Reagents: Methylamine Solvents: Toluene,Water; 24 H,20 - 30 °C
    标题:Method For Preparation Of (Z)-2-Oxo-1-Phenyl--3-Oxabicyclo[3,1,0]Hexane Via Condensation Of 2-Phenylacetonitrile And 2-(Chloromethyl)Oxiane
    参考文献:World Intellectual Property Organization]

    105310-75-6 = 92623-85-3
    反应条件:1.1 Reagents: Methylamine Solvents: Water; Rt; Rt -> 45 °C; 2 H,40 - 45 °C
    标题:Process For Preparation Of Milnacipran Intermediate And Its Use In Preparation Of Pure Milnacipran
    参考文献:World Intellectual Property Organization]

    105310-75-6 = 92623-85-3
    反应条件:1.1 Reagents: Methylamine Solvents: Toluene,Water; 10 - 15 °C; 20 H,25 - 30 °C
    标题:Process For Preparation Milnacipran Crystalline Form G Via Treatment Of The Phthalimide Derivative With Methylamine In An Organic Solvent
    参考文献:United States]

    = 92623-85-3 [标题:Reaction Conditions
    标题:Process For Preparing Optically Pure Milnacipran And Its Pharmaceutically Acceptable Salts
    参考文献:United States]

    = 92623-85-3 [标题:Reaction Conditions
    标题:Toward A Large-Scale Approach To Milnacipran Analogues Using Diazo Compounds In Flow Chemistry
    作者:Muller,Simon T. R.; Murat,Aurelien; Hellier,Paul; Wirth,Thomas
    参考文献:Organic Process Research & Development 日期:2016 卷标:20(2) 页码:495-502]

    = 92623-85-3 [标题:Reaction Conditions
    标题:Synthesis And Characterization Of Process Related Impurities Of (+/-)-Milnacipran
    作者:Gopal,P. Raja; Prabakar,A. Christy; Chandrashekar,E. R. R.; Bhaskar,B. Vijaya; Somaiah,P. Veera
    参考文献:Journal Of The Chinese Chemical Society (Weinheim 日期:2013 卷标:60(6) 页码:639-644]

    = 92623-85-3 [标题:Reaction Conditions
    标题:Preparation Of Milnacipran Hydrochloride And Intermediates Thereof
    作者:Anonymous
    参考文献:Ip.Com Journal 日期:2012 卷标:12

海关参考信息

专利信息


专利号:US-9353057-B2
优先权日:2003-12-30
标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
权利人:XENOPORT INC
摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

专利号:US-7576211-B2
优先权日:2004-09-30
标题 :Synthesis of thienopyridinone compounds and related intermediates
发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; CHEN DONGLI; MARANTZ YAEL; SHACHAM SHARON; HEIFETZ ALEXANDER; INBAL BOAZ; BAR-HAIM SHAY; MOHANTY PRADYUMNA; LOBERA MERCEDES; WU LAURENCE
权利人:EPIX DELAWARE INC
摘要:The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

专利号:US-2018148745-A1
优先权日:2015-05-26
标题:Hemoprotein catalysts for improved enantioselective enzymatic synthesis of ticagrelor
发明人:ARNOLD FRANCIS H; RENATA HANS; MCINTOSH JOHN A; LEWIS RUSSELL D; KAN SEK BIK JENNIFER; HERNANDEZ KARI; COELHO PEDRO; ROZZELL DAVID; ZHANG CHEN
权利人:CALIFORNIA INST OF TECHN; PROVIVI INC
摘要:The present invention provides methods by which trans-(1R,2S)-2-(3,4-difluorophenyl)-cyclopropylamine and related cyclopropane compounds are prepared using synthetic strategies that include a biocatalytic cyclopropanation step.

专利号:US-8604241-B2
优先权日:2009-01-29
标题:Method for synthesis of (1S, 2R)-milnacipran
发明人:NICOLAS MARC; HELLIER PAUL; DIARD CATHERINE; SUBRA LAURENT
权利人:NICOLAS MARC; HELLIER PAUL; DIARD CATHERINE; SUBRA LAURENT; PF MEDICAMENT
摘要:The present invention relates to a method for synthesizing a pharmaceutically acceptable acid addition salt of (1S, 2R)-milnacipran comprising the following successive steps: (a) reaction of phenylacetonitrile and of (R)-epichlorhydrin in the presence of a base containing an alkaline metal, followed by a basic treatment, and then by an acid treatment in order to obtain a lactone; (b) reaction of said lactone with MNEt 2 , wherein M represents an alkaline metal, or with NHEt 2 in the presence of a Lewis acid-amine complex, in order to obtain an amide-alcohol; (c) reaction of said amide-alcohol with thionyl chloride in order to obtain a chlorinated amide; (d) reaction of said chlorinated amide with a phthalimide salt in order to obtain a phthalimide derivative; (e) hydrolysis of the phthalimide group of said phthalimide derivative in order to obtain (1S, 2R)-milnacipran, and (f) salification of (1S, 2R)-milnacipran in a suitable solvent system in the presence of a pharmaceutically acceptable acid.

专利号:US-2015158809-A9
优先权日:2013-02-26
标 题 :Method of making 1-(acyloxy)-alkyl carbamate compounds
发明人:WANG HUAN; LIU PENG; DAI QUNYING; YIN HAO; RAILLARD STEPHEN P
权利人:XENOPORT INC
摘要:Methods of preparing carbamate prodrugs of amine-containing drugs are provided. Carbonates useful in the synthesis of the carbamate prodrugs are also provided.

专利号:US-2008214827-A1
优先权日:2004-02-03
标 题:Synthesis of Cyanoimino-Benzoimidazoles
发明人:GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
权利人:EURO CELTIQUE SA
摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.
安徽曦旺医药有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.sunwisepharm.com
电话: 18856027890 18856027890👤
📞安徽曦旺医药有限公司 ⚠️参考联系方式

销售电话:18856027890 18856027890
邮箱:sales@sunwisepharm.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Cording M, Derry S, Phillips T, Moore RA, Wiffen PJ. Milnacipran for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2015 Oct 20;10:CD008244. doi: 10.1002/14651858.CD008244.pub3. Review. doi: 10.1002/14651858.CD011789. Review. doi: 10.1517/14656566.2013.779670. Epub 2013 Mar 19. Review. doi: 10.1002/14651858.CD008244.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;10:CD008244.
5: Häuser W, Petzke F, Üçeyler N, Sommer C. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology (Oxford). 2011 Mar;50(3):532-43. doi: 10.1093/rheumatology/keq354. Epub 2010 Nov 14. Review.

合成参考文献


参考文献:10.3899/jrheum.090884
摘要:Branco JC, Zachrisson O, Perrot S, Mainguy Y; Multinational Coordinator Study Group. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol. 2010 Apr;37(4):851–9. doi: 10.3899/jrheum.090884.
参考文献:10.1007/s11940-011-0137-6
摘要:Hirai N, Nishino S. Recent advances in the treatment of narcolepsy. Curr Treat Options Neurol. 2011 Oct;13(5):437–57. doi: 10.1007/s11940-011-0137-6.
参考文献:10.2147/ndt.s19611
摘要:Montgomery S, Briley M. Noradrenergic symptom cluster in depression. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):1–2.
参考文献:10.2147/ndt.s19613
摘要:Blier P, Briley M. The noradrenergic symptom cluster: clinical expression and neuropharmacology. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):15–20.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知